1. Thethi TK. et al. Consequence of delayed pump infusion line change in patients with type 1 diabetes mellitus treated with continuous subcutaneous insulin infusion. J Diabetes Complication 2010; 24(2):73-78.
2. Pfützner A, et al. Using Insulin Infusion Sets in CSII for Longer Than the Recommended Ussage Time Leads to a High Risk for Adverse Events: Results From a Prospective Randomized Crossover Study. J Diabetes Sci Technol. 2015; 9(6):1292-1298

Katso käyttöaiheet, vasta-aiheet, varotoimet, varoitukset ja mahdolliset haittatapahtumat käyttöohjeista